Xenetic Biosciences, Inc. (NASDAQ:XBIO) | Finanzwire

Basculer en Français

9477	Companies
185475	Keywords
117817	Articles
99317	Press releases

Headlines Articles Press releases Xenetic Biosciences, Inc.

Home
Companies
Xenetic Biosciences, Inc.

BRIEF

published on 03/19/2025 at 13:10, 8 months 17 days ago

Xenetic Biosciences Reports 2024 Financial Results

Financial Results Cancer Treatment Clinical Development Collaborations DNase Technology
PRESS RELEASE

published on 03/19/2025 at 13:05, 8 months 17 days ago

Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results
Xenetic Biosciences reports encouraging preclinical data on DNase-based technology targeting NETosis for difficult cancers. Focus on clinical studies partnerships and DNase I development program for pancreatic carcinoma

Xenetic Biosciences Preclinical Data Clinical Studies DNase-based Technology NETosis
BRIEF

published on 03/13/2025 at 13:35, 8 months 23 days ago

Xenetic Biosciences Reveals Promising Preclinical Data for DNase I in Cancer Therapy

Xenetic Biosciences Cancer Treatment Preclinical Data DNase I Therapy CAR T Cells
PRESS RELEASE

published on 03/13/2025 at 13:30, 8 months 23 days ago

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses
Xenetic Biosciences presents promising findings on combining DNase I with CAR T cells to enhance cancer treatment strategies at the SITC Spring Scientific 2025 Cell Therapy Meeting

Xenetic Biosciences Cancer Treatment DNase I CAR T Cells SITC Spring Meeting
BRIEF

published on 02/27/2025 at 15:20, 9 months 5 days ago

Xenetic Biosciences' Abstract Accepted for SITC 2025 Meeting

Xenetic Biosciences Immuno-oncology Cell Therapy DNase Platform SITC 2025
PRESS RELEASE

published on 02/27/2025 at 15:15, 9 months 5 days ago

Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting
Xenetic Biosciences announces abstract acceptance for SITC Spring Scientific 2025 Cell Therapy Meeting on targeting Neutrophil Extracellular Traps in Metastatic Melanoma

Xenetic Biosciences DNase Platform Poster Presentation Immuno-oncology Technologies SITC Spring Scientific 2025
BRIEF

published on 12/17/2024 at 15:20, 11 months 18 days ago

Xenetic Biosciences Extends Research Agreement with University of Virginia

Xenetic Biosciences University Of Virginia Cancer Treatment DNase Platform Immune-oncology
PRESS RELEASE

published on 12/17/2024 at 15:15, 11 months 18 days ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Xenetic extends Research Agreement with University of Virginia for DNase-Based oncology platform. Dr. Reid Bissonnette discusses the advancement of innovative immune-oncology technologies

University Of Virginia Xenetic Research Agreement DNase-Based Oncology Platform
BRIEF

published on 12/16/2024 at 15:05, 11 months 19 days ago

Xenetic Biosciences Extends Research Agreement with UVA for DNase Oncology Platform

Xenetic Biosciences University Of Virginia Immunotherapy DNase Oncology NETs
PRESS RELEASE

published on 12/16/2024 at 15:00, 11 months 19 days ago

Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform
Xenetic Biosciences extends Research Funding Agreement with UVA to develop systemic DNase program targeting NETs to improve cancer therapy outcomes

Xenetic Biosciences DNase Program Cancer Therapy Immunotherapy NETs

Accesswire

Published on 12/05/2025 at 14:00, 50 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 50 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 15 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 12 hours 20 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 50 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 14:22, 27 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 33 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 39 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 4 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 49 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting

Les Echos

Published on 12/05/2025 at 08:45, 6 hours 5 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 20 hours 50 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 21 hours 5 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 21 hours 5 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 7 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE